International Stem Cell Corporation
ISCO
$0.11
-$0.001-0.90%
OTC PK
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 29.49% | 10.44% | 26.62% | 2.06% | -22.26% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 29.49% | 10.44% | 26.62% | 2.06% | -22.26% |
| Cost of Revenue | 14.72% | 24.71% | 28.05% | 7.65% | -24.03% |
| Gross Profit | 41.91% | 1.09% | 25.71% | -1.58% | -20.71% |
| SG&A Expenses | -5.16% | -2.29% | -3.24% | 11.48% | 28.14% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 3.55% | 9.61% | 9.92% | 10.70% | -2.36% |
| Operating Income | 112.03% | 7.22% | 203.47% | -9,000.00% | -795.08% |
| Income Before Tax | 102.40% | 4.58% | -75.81% | -529.41% | -2,091.30% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 102.40% | 4.58% | -75.81% | -529.41% | -2,091.30% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 102.40% | 4.58% | -75.81% | -529.41% | -2,091.30% |
| EBIT | 112.03% | 7.22% | 203.47% | -9,000.00% | -795.08% |
| EBITDA | 127.93% | 26.00% | 307.29% | -343.40% | -432.74% |
| EPS Basic | 103.69% | 4.88% | -76.23% | -535.71% | -1,406.90% |
| Normalized Basic EPS | 102.51% | 3.92% | 169.40% | -518.52% | -2,088.89% |
| EPS Diluted | 103.69% | 4.88% | -76.23% | -614.29% | -1,406.90% |
| Normalized Diluted EPS | 102.51% | 3.92% | 169.40% | -518.52% | -2,088.89% |
| Average Basic Shares Outstanding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Average Diluted Shares Outstanding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |